BioImplant ITN · European Training Network to develop Improved Bioresorbable Materials for Orthopaedic and Vascular Implant Applications
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2019-01-01 → 2023-06-30
- EU contribution
- €3,316,931
- Participants
- 9
- Scheme
- MSCA-ITN
Lines connect the coordinator with its partners.
Results in brief
European Training Network to develop Improved Bioresorbable Materials for Orthopaedic andVascular Implant Applications
BioImplant Innovative Training Network (ITN) is a European Industrial Doctorate (EID) programme that is providing world-class multidisciplinary skills to 12 Early Stage Researchers (ESRs) through an integrated research & training programme in the area of bioabsorbable medical implant development. Bioabsorbable materials are a category of biomaterial that gradually degrade when implanted in a biological environment. They have the potential to form the basis for the next-generation of vascular and orthopaedic medical implants as they can reduce the need for revision surgeries and avoid biocompatibility issues associated with conventional permanent implants. However, several issues relating to poor mechanical properties and/or uncontrollable degradation behaviour of current materials has presented significant technical challenges to the medical device sector. Furthermore, the stringent regulatory requirements associated with a “step-change” technology in the industry has formed a barrier to innovation in the field of bioabsorbables. The programme vision of the BioImplant ITN is to develop improved bioabsorbable materials for medical implant applications and deliver technical, interdisciplinary and transferrable skills training to the ESRs throughout all stages of the development process. The multidisciplinary training programme delivered to ESRs during the BioImplant ITN programme will enhance career development and employability, promoting their development into leading innovators in the European Medical Technology sector. The training objectives of BioImplant ITN are centred on upskilling the ESRs in core technical skills across all elements of the Supply Value Chain, delivering advanced technical skills through industry-led network-wide training events, providing key transferable and interdisciplinary skills, as well as promoting international mobility of ESRs through inter-sectoral secondments. The scientific objective of the BioImplant ITN is to develop and implement improved bioabsorbable materials for vascular and orthopaedic implant applications, by focussing on key areas such as enhancing the mechanical properties of polymer-based bioabsorbable material, controlling degradation rates of magnesium-based bioabsorbable materials and developing novel metal- and ceramic-based polymer composite bioabsorbables. The development of these innovative biomaterials will represent a major advancement on the current state-of-the-art in bioresorbable materials and maximise commercial potential in vascular and orthopaedic applications.
Data: CORDIS, © European Union
Project objective
BioImplant ITN is a European Industrial Doctorate (EID) programme that will provide world-class multidisciplinary training to a new generation of high-achieving ESRs in the area of medical device development. A well-balanced consortium of academic, industry and clinical partners has been assembled to deliver the training programme, spanning a number of EU countries and industry sectors to promote international, interdisciplinary and inter-sectoral aspects of ESR skill development. The programme vision of the BioImplant ITN is to deliver technical, interdisciplinary and transferrable skills training to the ESR community all areas of the medical device development Supply Value Chain. The BioImplant ITN programme will develop improved bioresorbable materials and implement them in orthopaedic and vascular implant applications. Bioresorbable materials are rapidly gaining traction in soft and hard tissue medical implants, with both polymer- and metal-based resorbable materials having been developed for medical device applications. However, major issues relating to their poor mechanical properties and rapid degradation behaviour have limited their application. The research programme of the BioImplant ITN will address these issues by (i) targeting new processing solutions to enhance the mechanical behaviour of bioresorbable polymers and (ii) integrate high stiffness magnesium- and ceramic-based reinforcements with polymers to produce novel hybrid/composite materials with optimised functional performance. The development of these innovative biomaterials will represent a major advancement on the current state-of-the-art in bioresorbable materials and maximise commercial potential in vascular and orthopaedic applications. Furthermore, the comprehensive skillset delivered by the programme will enhance career development and employability of ESRs within the Medical Technology sector and promote their development into leading innovators in the European Medical Technology sector.
Original text from CORDIS.
Participants
- UNIVERSITY OF GALWAY · GalwayCoordinatorIreland
- ADVANCED THREE D TECHNOLOGY LIMITED · GALWAYIreland
- BOSTON SCIENTIFIC LIMITED · GalwayIreland
- FUNDACION IMDEA MATERIALES · GetafeSpain
- ITA TECHNOLOGIETRANSFER GMBH · AachenGermany
- MEOTEC GMBH · AachenGermany
- RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN · AachenGermany
- THE QUEEN'S UNIVERSITY OF BELFAST · BELFASTUnited Kingdom
- VASCULAR FLOW TECHNOLOGIES LIMITED · DundeeUnited Kingdom
Links
- View on CORDIS
- DOI: 10.3030/813869
- http://www.bioimplantitn.eu
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5c6254ddb&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5c628fda2&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f7150c2d&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5fd1d4dff&appId=PPGMS
Data: CORDIS, © European Union
